Gilead Sciences expands regional footprint with new Dubai office

Publish May 31, 2022
real estate

Gilead Sciences, a US research-based biopharmaceutical company, has announced the opening of its new office in Dubai.

Headquartered in Foster City, California, the company focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza and Covid-19.

The launch of the new office comes as part of its efforts to grow its regional footprint and expand its portfolio across areas such as Covid-19 and oncology, said statement from Gilead Sciences.

The opening ceremony was attended by senior officials including Dr Amin Hussein Al Amiri, Assistant Under-Secretary for the Health Regulation Sector, Ministry of Health and Prevention; Helal Saeed Al Marri, Director-General of the Dubai Department of Economy and Tourism; Prof. Alawi Alsheikh-Ali, Deputy Director-General of Dubai Health Authority (DHA); Dr Younis Kazim, CEO of Dubai Healthcare Corporation and Dr. Ali Al Sayed, Director of the Pharmaceutical Services Department at DHA.

On the new office, Dr Jacopo Andreose, Senior VP (Intercontinental and Global Patient Solutions) said: 'The pharmaceutical sector in the UAE is benefitting from a steady rise in population and net income and the roll-out of the mandatory health insurance scheme. The healthcare industry is marked by continued improvement and strategic investments in high-quality medical services by the leadership.'

'We are keen on growing our presence in the UAE and wider region and will continue to invest in infrastructure and talent to best capitalise on these positive trends and to deliver upon the promise of our bold and transformative science,' he added.

Middle East General Manager Frederico Silva said: 'Committed to grow as an employer of choice, our investments in state-of-the-art spaces to house our talent is reflective of our core values that guide our steadfast mission of developing and delivering innovative therapies within HIV, cancer, Covid-19 and viral hepatitis.'

'In our vision to create a healthier world for all people, delivering innovative medicines that aim to prevent, treat and cure life-threatening diseases, we are guided by a philosophy that by investing in our employee experience further we are able to better serve our patient communities,' he added.


Latest Stories

President Al-Mashat visits first conference for development of public finances

2021-09-20 06:00:00

SANA'A, Sep. 19 (Saba) – President of the Supreme Political Council Mahdi Al-Mashat visited on Sunday the first conference"...
Read More

Hospital in Sana'a launches free medical week

2021-09-12 03:00:00

SANA'A, Sep. 11 (Saba) - September 26 Hospital Authority in Bani Matar dstrict of Sana'a province launched on Saturday a"...
Read More

Yemeni restaurant opening in Newport: What you need to know

2021-09-09 06:00:00

NEWPORT is set to be home to what is calling itself the city’s “first Yemeni restaurant.”

Read More

Yemen Socio-Economic Update, Issue 59 - April 2021

2021-08-09 04:00:00
The impact of War.. The role of Women in Building Peace.. Required Interventions The Editorial Since the escalation of conflict and war, women in Yemen can said to be the most affected group in the society. These conditions have imposed a new reality on women and re-determined their roles and lifestyles,......
Read More